Integrated Diagnostics Holdings plc kicks-off 2025 on strong note with revenue climbing 35% and profitability maintaining improving trajectory
(London) — Integrated Diagnostics Holdings (“IDH,” “the Group,” or “the Company”), a leading provider of diagnostic services with operations in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan announced today its unaudited financial statements for the three-month period ended 31 March 2025. IDH recorded year-on-year revenue growth of 35% in the first quarter of 2025 with the Company’s top-line reaching EGP 1,583 million. Further down the income statement, the Company’s efforts to optimize operations and spending continued to support steady improvements in underlying profitability. More specifically, IDH saw its gross and EBITDA margins reach 40% and 31%, respectively, during the first quarter, marking substantial year-on-year improvements. Finally, it is important to note that the contraction seen in the Company’s bottom-line this quarter comes on the back of a normalisation in FX gains booked during the period, as local currencies in Egypt and Nigeria largely stabilised over the last twelve months. When controlling for FX gains in both periods, IDH’s normalised net profit more than doubled in Q1 2025 with the Company’s normalised bottom-line margin expanding by five percentage points versus the corresponding quarter of last year.